Indiana Unversity
Dr. Emma Tillman, PharmD, PhD is a clinical pharmacist and Research Associate Professor at Indiana University School of Medicine, specializing in using pharmacogenomics to enhance medication safety and optimize medication use. She is a member of the CFF working groups: PRIME (Prioritizing Research In MEntal Health) and CF Pharm. She is excited to offer her expertise in clinical pharmacology to collaborate and investigate adverse events in persons with cystic fibrosis.
Prevalence of Cannabidiol use in Persons with Cystic Fibrosis
Thursday, September 26, 2024
10:15 AM – 11:45 AM ET